Skip to content

In the BioHarmony Drug Report Database

Ropeginterferon alfa-2b

Besremi (ropeginterferon alfa-2b) is an unknown pharmaceutical. Ropeginterferon alfa-2b was first approved as Besremi on 2019-02-15. It has been approved in Europe to treat polycythemia vera.
Trade Name Besremi
Common Name Ropeginterferon alfa-2b
Indication polycythemia vera
Drug Class Pegylated compounds
Ropeginterferon alfa-2b
Get full access now